BackIVERIC bio Overview

IVERIC bio Long Term Debt

Track IVERIC bio's long-term debt ($97M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$96.99M
↑ 25091.43% YoYΔ $96.60M vs prior year quarter

Peer average

Loading

IVERIC bio Long Term Debt History

Loading

IVERIC bio vs. peers: Long Term Debt Comparison

Loading

IVERIC bio Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IVERIC bio (ISEE) FAQ

As of the most recent data (March 2023), ISEE shows a long-term debt of $97M. That compares with $390K in the prior-year period — up 25091.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ISEE's long-term debt is now $97M (was $390K) — a 25091.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether IVERIC bio is outperforming or lagging.

Tracking ISEE's long-term debt over time shows whether IVERIC bio is scaling, shrinking, or reshaping that part of the business. The current reading is $97M That compares with $390K in the prior-year period — up 25091.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has IVERIC bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $97M) with ownership activity and broader fundamentals.

IVERIC bio's long-term debt is $97M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.